197 related articles for article (PubMed ID: 1689621)
1. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Akhtar M; Breithardt G; Camm AJ; Coumel P; Janse MJ; Lazzara R; Myerburg RJ; Schwartz PJ; Waldo AL; Wellens HJ
Circulation; 1990 Mar; 81(3):1123-7. PubMed ID: 1689621
[No Abstract] [Full Text] [Related]
2. CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Eur Heart J; 1990 Mar; 11(3):194-9. PubMed ID: 2108031
[No Abstract] [Full Text] [Related]
3. Lessons from the cardiac arrhythmia suppression trial.
Garratt C; Ward DE; Camm AJ
BMJ; 1989 Sep; 299(6703):805-6. PubMed ID: 2510839
[No Abstract] [Full Text] [Related]
4. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.
Bigger JT
Am J Cardiol; 1990 Feb; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253
[TBL] [Abstract][Full Text] [Related]
5. The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
Bigger JT
J Am Coll Cardiol; 1990 Jan; 15(1):243-5. PubMed ID: 2104884
[No Abstract] [Full Text] [Related]
6. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
Cardiac Arrhythmia Pilot Study (CAPS) Investigators
Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
[TBL] [Abstract][Full Text] [Related]
7. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators
N Engl J Med; 1989 Aug; 321(6):406-12. PubMed ID: 2473403
[TBL] [Abstract][Full Text] [Related]
8. Flecainide and CAST.
Lancet; 1989 Aug; 2(8661):481-2. PubMed ID: 2570188
[No Abstract] [Full Text] [Related]
9. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Anderson JL
Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of CAST I and II.
Somberg J
J Clin Pharmacol; 1991 Nov; 31(11):1041. PubMed ID: 1721629
[No Abstract] [Full Text] [Related]
11. An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.
Coyle JD; Schaal SF
DICP; 1989 Jun; 23(6):478-9. PubMed ID: 2500783
[No Abstract] [Full Text] [Related]
12. Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis.
Pratt CM
Am J Cardiol; 1990 Feb; 65(8):51D-55D; discussion 68D-71D. PubMed ID: 1689536
[TBL] [Abstract][Full Text] [Related]
13. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
Epstein AE; Bigger JT; Wyse DG; Romhilt DW; Reynolds-Haertle RA; Hallstrom AP
J Am Coll Cardiol; 1991 Jul; 18(1):14-9. PubMed ID: 1904891
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Podrid PJ
Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
[No Abstract] [Full Text] [Related]
15. Drugs for cardiac arrhythmias: new warning.
Med Lett Drugs Ther; 1989 May; 31(792):48. PubMed ID: 2497313
[No Abstract] [Full Text] [Related]
16. Encainide for cardiac arrhythmias.
Med Lett Drugs Ther; 1987 May; 29(740):50-2. PubMed ID: 2437434
[No Abstract] [Full Text] [Related]
17. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
Greene HL; Roden DM; Katz RJ; Woosley RL; Salerno DM; Henthorn RW
J Am Coll Cardiol; 1992 Apr; 19(5):894-8. PubMed ID: 1552108
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ventricular arrhythmias after CAST.
Tonkin AM
Med J Aust; 1992 Apr; 156(7):488-92. PubMed ID: 1372950
[TBL] [Abstract][Full Text] [Related]
19. Crime, misdemeanor, and arrhythmia decoding CAST.
Kerin NZ
J Clin Pharmacol; 1991 Nov; 31(11):1044-52. PubMed ID: 1753008
[No Abstract] [Full Text] [Related]
20. Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the CAST study.
Bayés de Luna A; Guindo J; Borja J; Roman M; Madoery C
Cardiovasc Drugs Ther; 1990 Jun; 4(3):651-5. PubMed ID: 2127537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
